GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) » Definitions » Cyclically Adjusted Revenue per Share

Torrent Pharmaceuticals (NSE:TORNTPHARM) Cyclically Adjusted Revenue per Share : ₹292.57 (As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Torrent Pharmaceuticals Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Torrent Pharmaceuticals's adjusted revenue per share for the three months ended in Mar. 2025 was ₹85.925. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹292.57 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Torrent Pharmaceuticals's average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Torrent Pharmaceuticals was 9.60% per year. The lowest was 9.00% per year. And the median was 9.10% per year.

As of today (2025-06-03), Torrent Pharmaceuticals's current stock price is ₹3127.80. Torrent Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹292.57. Torrent Pharmaceuticals's Cyclically Adjusted PS Ratio of today is 10.69.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Torrent Pharmaceuticals was 12.40. The lowest was 4.78. And the median was 6.90.


Torrent Pharmaceuticals Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Torrent Pharmaceuticals's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torrent Pharmaceuticals Cyclically Adjusted Revenue per Share Chart

Torrent Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 207.66 225.95 251.31 273.18 292.57

Torrent Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 273.18 281.08 287.42 290.81 292.57

Competitive Comparison of Torrent Pharmaceuticals's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torrent Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Torrent Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.


;
;

Torrent Pharmaceuticals Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Torrent Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=85.925/157.5517*157.5517
=85.925

Current CPI (Mar. 2025) = 157.5517.

Torrent Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 55.709 99.841 87.911
201509 48.847 101.753 75.633
201512 44.990 102.901 68.884
201603 43.738 102.518 67.217
201606 44.768 105.961 66.565
201609 41.603 105.961 61.859
201612 41.557 105.196 62.240
201703 40.793 105.196 61.096
201706 39.369 107.109 57.910
201709 41.091 109.021 59.382
201712 41.660 109.404 59.994
201803 49.921 109.786 71.640
201806 54.345 111.317 76.917
201809 54.858 115.142 75.064
201812 57.411 115.142 78.557
201903 53.909 118.202 71.855
201906 58.274 120.880 75.953
201909 58.395 123.175 74.692
201912 56.609 126.235 70.653
202003 56.597 124.705 71.504
202006 59.542 127.000 73.866
202009 58.654 130.118 71.020
202012 58.164 130.889 70.012
202103 56.648 131.771 67.731
202106 62.733 134.084 73.713
202109 62.025 135.847 71.935
202112 61.920 138.161 70.611
202203 62.121 138.822 70.502
202206 67.659 142.347 74.886
202209 65.381 144.661 71.207
202212 72.675 145.763 78.553
202303 72.485 146.865 77.760
202306 75.361 150.280 79.007
202309 77.546 151.492 80.648
202312 79.576 152.924 81.984
202403 79.650 153.035 82.001
202406 83.218 155.789 84.160
202409 83.555 157.882 83.380
202412 81.707 158.323 81.309
202503 85.925 157.552 85.925

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Torrent Pharmaceuticals  (NSE:TORNTPHARM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Torrent Pharmaceuticals's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3127.80/292.57
=10.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Torrent Pharmaceuticals was 12.40. The lowest was 4.78. And the median was 6.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Torrent Pharmaceuticals Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Torrent Pharmaceuticals's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Torrent Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.

Torrent Pharmaceuticals Headlines

No Headlines